title: Clinical experience with intravenous zoledronic acid in the treatment of male osteoporosis: evidence and opinions.
abstract: Osteoporosis frequently remains underrecognized and undertreated in men. Most osteoporosis-related fractures could be prevented if men at risk would be diagnosed, treated, and remained compliant with therapy. Bisphosphonates, the mainstay of osteoporosis treatment, are potent antiresorptive agents that inhibit osteoclast activity, suppress in vivo markers of bone turnover, increase bone mineral density, decrease fractures, and likely improve survival in men with osteoporosis. The focus of the article is on intravenous zoledronic acid, which may be a preferable alternative to oral bisphosphonate therapy in patients with cognitive dysfunction, the inability to sit upright, polypharmacy, significant gastrointestinal pathology or suspected medication noncompliance. Zoledronic acid is approved in the United States (US) and European Union (EU) as an annual 5 mg intravenous infusion to treat osteoporosis in men. The zoledronic acid 4 mg intravenous dose has been studied in the prevention of bone loss associated with androgen deprivation therapy. This article reviews the evidence for zoledronic acid, currently the most potent bisphosphonate available for clinical use, and its therapeutic effects in the treatment of men with osteoporosis.
authors.affiliation: Department of Internal Medicine, Division of Endocrinology, Riga East Clinical University Hospital, Riga, Latvia.
authors.forename: Ieva
authors.initials: I
authors.lastname: Ruza
authors.forename: Sasan
authors.initials: S
authors.lastname: Mirfakhraee
authors.forename: Eric
authors.initials: E
authors.lastname: Orwoll
authors.forename: Ugis
authors.initials: U
authors.lastname: Gruntmanis
keywords: bisphosphonates; bone mineral density; fracture; men; osteoporosis; zoledronic acid
references.citation: J Bone Miner Res. 2007 Mar;22(3):465-75
references.pmid: 17144789
references.citation: Joint Bone Spine. 2009 Mar;76(2):129-33
references.pmid: 19176288
references.citation: Phys Ther. 1994 May;74(5):387-98
references.pmid: 8171100
references.citation: J Bone Miner Res. 1998 Dec;13(12):1915-23
references.pmid: 9844110
references.citation: J Clin Endocrinol Metab. 2012 Jun;97(6):1861-70
references.pmid: 22466344
references.citation: Osteoporos Int. 2006 Dec;17(12):1726-33
references.pmid: 16983459
references.citation: J Urol. 2003 Jun;169(6):2008-12
references.pmid: 12771706
references.citation: J Osteoporos. 2011;2011:924595
references.pmid: 21826255
references.citation: Bone. 2004 Jan;34(1):195-202
references.pmid: 14751578
references.citation: Osteoporos Int. 2012 Mar;23(3):1083-90
references.pmid: 21975559
references.citation: World Health Organ Tech Rep Ser. 1994;843:1-129
references.pmid: 7941614
references.citation: J Osteoporos. 2012;2012:675984
references.pmid: 22570804
references.citation: Ann Intern Med. 2008 May 6;148(9):680-4
references.pmid: 18458281
references.citation: QJM. 2009 Jan;102(1):35-42
references.pmid: 18842684
references.citation: J Urol. 2009 Nov;182(5):2257-64
references.pmid: 19758618
references.citation: JAMA. 2011 Jun 1;305(21):2184-92
references.pmid: 21632482
references.citation: Ann Intern Med. 2008 Feb 5;148(3):197-213
references.pmid: 18087050
references.citation: Cancer. 2009 Aug 1;115(15):3468-74
references.pmid: 19484786
references.citation: Osteoporos Int. 2011 Nov;22(11):2789-98
references.pmid: 21509585
references.citation: Bone. 2003 Nov;33(5):805-11
references.pmid: 14623056
references.citation: Mayo Clin Proc. 2007 Dec;82(12):1493-501
references.pmid: 18053457
references.citation: Arch Intern Med. 2002 Oct 28;162(19):2217-22
references.pmid: 12390065
references.citation: J Bone Miner Res. 2012 Dec;27(12):2544-50
references.pmid: 22836783
references.citation: J Bone Miner Res. 2012 Feb;27(2):243-54
references.pmid: 22161728
references.citation: N Engl J Med. 2007 May 3;356(18):1809-22
references.pmid: 17476007
references.citation: J Clin Endocrinol Metab. 2010 Sep;95(9):4380-7
references.pmid: 20554708
references.citation: J Clin Oncol. 2007 Mar 20;25(9):1038-42
references.pmid: 17369566
references.citation: J Clin Endocrinol Metab. 2007 Apr;92(4):1283-8
references.pmid: 17227801
references.citation: Osteoporos Int. 2009 Dec;20(12):2127-34
references.pmid: 19499273
references.citation: Stroke. 2007 May;38(5):1519-25
references.pmid: 17395868
references.citation: Mayo Clin Proc. 2002 Oct;77(10):1031-43
references.pmid: 12374247
references.citation: Arch Intern Med. 2003 Oct 13;163(18):2165-72
references.pmid: 14557214
references.citation: JAMA. 2011 Feb 23;305(8):783-9
references.pmid: 21343577
references.citation: J Oral Maxillofac Surg. 2005 Nov;63(11):1567-75
references.pmid: 16243172
references.citation: J Clin Endocrinol Metab. 2012 Jun;97(6):1871-80
references.pmid: 22466336
references.citation: Urology. 2002 Sep;60(3 Suppl 1):7-11; discussion 11-2
references.pmid: 12231037
references.citation: Prostate Cancer. 2011;2011:176164
references.pmid: 22110981
references.citation: Drug Metab Dispos. 2008 Oct;36(10):2043-9
references.pmid: 18625688
references.citation: N Engl J Med. 2002 Feb 28;346(9):653-61
references.pmid: 11870242
references.citation: Mayo Clin Proc. 2006 Aug;81(8):1013-22
references.pmid: 16901023
references.citation: Lancet. 2009 Apr 11;373(9671):1253-63
references.pmid: 19362675
references.citation: JAMA. 2009 Oct 14;302(14):1573-9
references.pmid: 19826027
references.citation: J Am Geriatr Soc. 2011 Nov;59(11):2084-90
references.pmid: 22091563
references.citation: Oncologist. 2004;9(3):319-29
references.pmid: 15169987
references.citation: J Bone Miner Res. 2007 Oct;22(10):1479-91
references.pmid: 17663640
references.citation: Osteoporos Int. 2003 Dec;14(12):965-8
references.pmid: 14504697
references.citation: Bone. 2011 Jul;49(1):77-81
references.pmid: 21232648
references.citation: N Engl J Med. 2010 Nov 18;363(21):2027-35
references.pmid: 21083387
references.citation: BJU Int. 2007 Jul;100(1):70-5
references.pmid: 17552955
references.citation: J Urol. 2006 Sep;176(3):972-8; discussion 978
references.pmid: 16890673
references.citation: BJU Int. 2010 Apr;105(8):1082-8
references.pmid: 19912210
references.citation: Osteoporos Int. 2007 Aug;18(8):1023-31
references.pmid: 17308956
references.citation: J Osteoporos. 2011;2011:704015
references.pmid: 22220284
references.citation: Bone. 1995 Nov;17(5 Suppl):501S-503S
references.pmid: 8573427
references.citation: J Clin Endocrinol Metab. 2012 Jun;97(6):1802-22
references.pmid: 22675062
references.citation: Osteoporos Int. 2008 Jun;19(6):733-59
references.pmid: 18214569
references.citation: J Am Dent Assoc. 2010 Nov;141(11):1365-70
references.pmid: 21037195
references.citation: Urology. 2010 May;75(5):1138-43
references.pmid: 20303574
references.citation: J Bone Miner Res. 2010 Nov;25(11):2267-94
references.pmid: 20842676
references.citation: Proc Natl Acad Sci U S A. 2006 May 16;103(20):7829-34
references.pmid: 16684881
references.citation: Arch Intern Med. 2008 Apr 28;168(8):826-31
references.pmid: 18443257
references.citation: N Engl J Med. 2012 Jul 5;367(1):40-9
references.pmid: 22762317
references.citation: J Clin Endocrinol Metab. 2011 Jul;96(7):1955-9
references.pmid: 21508139
references.citation: N Engl J Med. 2011 May 5;364(18):1728-37
references.pmid: 21542743
references.citation: Kidney Int. 2008 Sep;74(5):641-8
references.pmid: 18509324
references.citation: Kidney Int. 2008 Dec;74(11):1385-93
references.pmid: 18685574
references.citation: Am J Med. 2013 Jan;126(1):13-20
references.pmid: 23177553
references.citation: J Clin Endocrinol Metab. 2012 Jun;97(6):1922-8
references.pmid: 22419728
references.citation: Clin Genitourin Cancer. 2007 Mar;5(4):271-7
references.pmid: 17553207
references.citation: Osteoporos Int. 2004 Feb;15(2):120-4
references.pmid: 14618302
references.citation: J Bone Miner Res. 2010 Jan;25(1):2-10
references.pmid: 20091928
references.citation: J Clin Endocrinol Metab. 2010 Jul;95(7):3251-9
references.pmid: 20444916
references.citation: Clin Interv Aging. 2009;4:289-303
references.pmid: 19750231
references.citation: J Clin Endocrinol Metab. 2012 Aug;97(8):2670-81
references.pmid: 22605432
references.citation: Arthritis Res Ther. 2010;12(1):R30
references.pmid: 20170505
references.citation: Bone. 1996 Feb;18(2):75-85
references.pmid: 8833200
references.citation: Clin Ther. 2010 Mar;32(3):426-36
references.pmid: 20399982
references.citation: Contemp Clin Trials. 2005 Oct;26(5):569-85
references.pmid: 16084776
references.citation: N Engl J Med. 2012 Nov;367(18):1714-23
references.pmid: 23113482
references.citation: J Pharmacol Exp Ther. 2001 Feb;296(2):235-42
references.pmid: 11160603
references.citation: Bone. 2012 May;50(5):1196-200
references.pmid: 22366401
references.citation: Bone. 2012 Jan;50(1):289-95
references.pmid: 22061864
references.citation: Osteoporos Int. 2011 Jan;22(1):21-6
references.pmid: 20458571
references.citation: N Engl J Med. 2010 May 13;362(19):1761-71
references.pmid: 20335571
references.citation: J Interferon Cytokine Res. 2003 Nov;23(11):649-54
references.pmid: 14651779
references.citation: J Bone Miner Res. 1995 Oct;10(10):1478-87
references.pmid: 8686503
references.citation: N Engl J Med. 2007 Nov 1;357(18):1799-809
references.pmid: 17878149
references.citation: N Engl J Med. 2005 Jan 13;352(2):154-64
references.pmid: 15647578
references.citation: Clin Infect Dis. 2010 Oct 15;51(8):937-46
references.pmid: 20839968
references.citation: Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5406-10
references.pmid: 17875770
references.citation: N Engl J Med. 2003 Jun 26;348(26):2635-45
references.pmid: 12826639
references.citation: Am J Med Sci. 2007 Feb;333(2):85-92
references.pmid: 17301586
references.citation: J Clin Endocrinol Metab. 2012 Jul;97(7):2272-82
references.pmid: 22523337
references.citation: Arch Intern Med. 2012 Mar 26;172(6):477-83
references.pmid: 22371876
references.citation: Osteoporos Int. 2011 Aug;22(8):2337-45
references.pmid: 21116816
references.citation: Arthritis Care Res (Hoboken). 2010 Nov;62(11):1515-26
references.pmid: 20662044
references.citation: Endocr Rev. 2008 Jun;29(4):441-64
references.pmid: 18451258
references.citation: Ann Intern Med. 2006 May 16;144(10):753-61
references.pmid: 16702591
references.citation: J Bone Miner Res. 2007 Feb;22(2):211-9
references.pmid: 17059373
references.citation: Osteoporos Int. 2008 Apr;19(4):385-97
references.pmid: 18292978
references.citation: Drugs Aging. 2007;24(1):37-55
references.pmid: 17233546
references.citation: Am J Med. 2007 Mar;120(3):251-6
references.pmid: 17349448
references.citation: J Bone Miner Res. 2010 Oct;25(10):2239-50
references.pmid: 20499357
references.citation: Oncologist. 2004;9 Suppl 4:3-13
references.pmid: 15459425